{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:21:05Z","timestamp":1758154865740,"version":"3.44.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Semyon and Janna Friedman Foundation"},{"name":"Talles Family HCM Research Fund"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jaccas.2025.104495","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T18:36:12Z","timestamp":1754505372000},"page":"104495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Concurrent Use of Tafamidis and Mavacamten for Transthyretin Cardiac Amyloidosis With Severe Outflow Tract Obstruction"],"prefix":"10.1016","volume":"30","author":[{"given":"Ali Asghar","family":"Kassamali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joban","family":"Vaishnav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Czarny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Blake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6743-8395","authenticated-orcid":false,"given":"Vrinda","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9422-6742","authenticated-orcid":false,"given":"Stefan L.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Madrazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5589-1216","authenticated-orcid":false,"given":"Richard T.","family":"Carrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccas.2025.104495_bib1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaccao.2021.08.009","article-title":"Temporal trends of wild-type transthyretin amyloid cardiomyopathy in the transthyretin amyloidosis outcomes survey","volume":"3","author":"Nativi-Nicolau","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccas.2025.104495_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005588","article-title":"Echo parameters for differential diagnosis in cardiac amyloidosis: a head-to-head comparison of deformation and nondeformation parameters","volume":"10","author":"Pagourelias","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jaccas.2025.104495_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jaccas.2025.104495_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10554-023-02994-9","article-title":"Assessment of left ventricular global longitudinal strain in patients with hypertrophic cardiomyopathy and coronary artery disease","volume":"40","author":"Gjergjindreaj","year":"2024","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jaccas.2025.104495_bib5","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jaccas.2025.104495_bib6","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.3390\/jcm12103481","article-title":"Cardiac magnetic resonance in HCM phenocopies: from diagnosis to risk stratification and therapeutic management","volume":"12","author":"Licordari","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaccas.2025.104495_bib7","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jaccas.2025.104495_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014938","article-title":"Identification of transthyretin cardiac amyloidosis among patients previously diagnosed with hypertrophic cardiomyopathy","volume":"15","author":"Rowin","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jaccas.2025.104495_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007558","article-title":"False-positive (99m)Technetium-pyrophosphate scintigraphy in two patients with hypertrophic cardiomyopathy","volume":"14","author":"Schafer","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jaccas.2025.104495_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cardfail.2023.10.279","article-title":"Left ventricular outflow tract obstruction in cardiac amyloidosis","volume":"30","author":"Longinow","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.jaccas.2025.104495_bib11","first-page":"860","article-title":"Mitral valve interventions for hypertrophic obstructive cardiomyopathy","volume":"40","author":"Shuvy","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jaccas.2025.104495_bib12","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jacc.2024.02.007","article-title":"Transcatheter myotomy to reduce left ventricular outflow obstruction","volume":"83","author":"Greenbaum","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccas.2025.104495_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034069","article-title":"Eighteen-month real-world experience using mavacamten for treatment of obstructive hypertrophic cardiomyopathy in a racially diverse population","volume":"13","author":"Ramonfaur","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jaccas.2025.104495_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jchf.2023.09.028","article-title":"Mavacamten treatment for symptomatic obstructive hypertrophic cardiomyopathy: interim results from the MAVA-LTE study, EXPLORER-LTE cohort","volume":"12","author":"Rader","year":"2024","journal-title":"JACC Heart Fail"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925012756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925012756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:11:07Z","timestamp":1758132667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084925012756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":14,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2666084925012756"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.104495","relation":{},"ISSN":["2666-0849"],"issn-type":[{"type":"print","value":"2666-0849"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent Use of Tafamidis and Mavacamten for Transthyretin Cardiac Amyloidosis With Severe Outflow Tract Obstruction","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.104495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"104495"}}